Greenway Greenhouse Cannabis Corp. (GWAY) AI Stock Analysis

• Market Cap: C$30.25M
• Dividend Yield: N/A
• Average Volume (3M): 9.35K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.82
• Revenue Growth: 44.21%
• EPS Growth: 21.93%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 65
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.03
• Shares Outstanding: 131,528,810
• 10 Day Avg. Volume: 4,576
• 30 Day Avg. Volume: 9,349
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 3.90
• Price to Cash Flow (P/CF): 172.10
• P/FCF Ratio: 25.30
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

The overall score reflects significant revenue growth and strategic corporate actions but is weighed down by financial strain and technical bearish trends. The financial performance remains a key concern with high leverage and cash flow issues, while technical indicators suggest caution. Positive corporate events offer potential upside if financial weaknesses are addressed.

Greenway Greenhouse Cannabis Corp. Business Overview & Revenue Model

Company Description

Greenway Greenhouse Cannabis Corp. (GWAY) is a company operating in the agricultural and cannabis sectors. It specializes in the cultivation, production, and distribution of high-quality cannabis products, leveraging advanced greenhouse technology to optimize growth conditions and ensure sustainable practices. The company is committed to providing premium cannabis to both medical and recreational markets, with a focus on innovation, quality, and environmental responsibility.

How the Company Makes Money

Greenway Greenhouse Cannabis Corp. generates revenue primarily through the sale of its cannabis products to various markets, including medical dispensaries and recreational retailers. The company utilizes its state-of-the-art greenhouse facilities to produce cannabis efficiently and sustainably, reducing costs and enhancing product quality. Revenue streams include the sale of dried cannabis flowers, oils, and other derivative products. Key partnerships with distributors and retailers help expand the company's reach and market presence, contributing significantly to its earnings. Additionally, Greenway may engage in strategic collaborations or white-label agreements to further diversify its revenue sources.

Greenway Greenhouse Cannabis Corp. Financial Statement Overview

Summary

Greenway Greenhouse Cannabis Corp. exhibits significant revenue growth, but profitability and cash flow challenges persist. High leverage and negative earnings margins signal financial strain, while cash flow issues may hinder operational sustainability. The company must address these areas to improve its financial health.

Income Statement

The company shows a negative gross profit margin and net profit margin in the TTM, indicating difficulty in covering costs. Revenue has grown significantly from the previous year, suggesting potential market expansion. However, the negative EBIT and EBITDA margins reflect operational inefficiencies.

Balance Sheet

The debt-to-equity ratio is high, indicating significant leverage, and the equity ratio shows low equity relative to total assets. ROE is negative due to net losses, highlighting profitability challenges. The balance sheet reflects a risk of financial instability.

Cash Flow

Free cash flow is negative, and both operating and free cash flow to net income ratios are unfavorable, indicating cash flow issues. The growth rate of free cash flow is not positive, suggesting the company struggles to generate cash from operations.

Breakdown
TTM	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Income Statement		Total Revenue
7.36M	5.23M	5.62M	1.98M	0.00	0.00
	Gross Profit
-419.25K	-335.38K	741.99K	844.02K	487.88K	-465.31K
	EBIT
-2.77M	-3.88M	-2.10M	-2.32M	-1.24M	-2.08M
	EBITDA
-780.49K	-2.21M	-632.92K	-1.36M	-727.12K	-1.57M
	Net Income Common Stockholders
-3.59M	-4.72M	-2.61M	-2.92M	-1.23M	-2.18M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
2.16M	1.53M	3.64M	7.48M	3.46M	1.44M
	Total Assets
31.62M	33.09M	35.30M	35.63M	25.11M	17.61M
	Total Debt
15.85M	16.02M	13.96M	16.67M	13.85M	8.00M
	Net Debt
13.69M	14.49M	10.31M	9.19M	10.39M	6.56M
	Total Liabilities
21.86M	21.17M	20.36M	18.77M	14.85M	8.74M
	Stockholders Equity
9.76M	11.92M	14.95M	16.86M	10.26M	8.87M
Cash Flow		Free Cash Flow
-732.92K	-4.96M	-4.38M	-4.10M	-5.95M	-5.53M
	Operating Cash Flow
-32.11K	-2.05M	2.23M	-1.97M	-592.08K	-441.11K
	Investing Cash Flow
-700.81K	-2.92M	428.31K	-2.12M	-5.36M	-5.09M
	Financing Cash Flow
537.50K	2.85M	-6.49M	8.12M	7.97M	5.82M

Greenway Greenhouse Cannabis Corp. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 0.22
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:GWAY, the sentiment is Neutral. The current price of 0.22 is above the 20-day moving average (MA) of 0.20, below the 50-day MA of 0.23, and below the 200-day MA of 0.30, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 57.72 is Neutral, neither overbought nor oversold. The STOCH value of 76.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for TSE:GWAY.

Greenway Greenhouse Cannabis Corp. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CRON	67 Neutral	$979.28M	17.25	3.80%	―	35.87%	―
ACB	55 Neutral	$325.46M	25.51	4.78%	―	16.39%	-98.10%
WEED	53 Neutral	$298.80M	―	-84.50%	―	-16.27%	―
OGI	53 Neutral	C$200.75M	―	-18.27%	―	7.33%	84.41%
Sector *	51 Neutral	$5.31B	3.33	-39.82%	2.92%	17.95%	1.84%
GWAY	44 Neutral	C$30.25M	―	-31.24%	―	44.21%	21.93%

Greenway Greenhouse Cannabis Corp. Corporate Events

Greenway Greenhouse Cannabis Reports Strong Q3 Growth Amid Rising Cannabis Prices

Greenway Greenhouse Cannabis Corporation reported a 21% increase in net revenue for the third quarter of 2025, compared to the same period in 2024, reaching $1,676,721. The company also saw a 57% increase in net revenue for the nine months ending December 31, 2024, surpassing the previous full fiscal year. The company attributes its growth to rising cannabis prices and the successful launch of new products and brands in the Canadian recreational market. Greenway’s MillRite brand maintained its strong market position, and the company is looking to expand its distribution both domestically and internationally as the Canadian cannabis industry rebounds.

Greenway Greenhouse Expands Product Line and Issues Shares

Greenway Greenhouse Cannabis Corporation has announced the launch of two new SKUs under its MillRite product line in Ontario. The new offerings include a 10×0.35g Lavender Haze pre-roll and a 14g milled-flower SKU named Blue Crush, marking the company’s entry into the milled flower market. This expansion reflects Greenway’s strategy to capitalize on its successful pre-roll products and meet consumer demands for premium, high-quality cannabis products. Additionally, Greenway issued 295,792 common shares to Abingdon Capital Corporation as part of a corporate-finance advisory services agreement, adhering to Canadian securities laws.